Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model
- Authors
- Lee, Onseok; Kim, Jaeyoung; Choi, Young Wook; Lee, Minwon; Park, Gyuman; Oh, Chilhwan
- Issue Date
- Dec-2013
- Publisher
- WILEY
- Keywords
- calipers; melanoma; micro-PET; CT; oregonin; stereo image
- Citation
- EXPERIMENTAL DERMATOLOGY, v.22, no.12, pp 842 - 844
- Pages
- 3
- Journal Title
- EXPERIMENTAL DERMATOLOGY
- Volume
- 22
- Number
- 12
- Start Page
- 842
- End Page
- 844
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14107
- DOI
- 10.1111/exd.12277
- ISSN
- 0906-6705
1600-0625
- Abstract
- Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. B16 melanoma cells were separated with trypsin-ethylenediaminetetraacetic acid, resuspended in 50l of phosphate-buffered saline and transplanted into the backs of 6- to 8-week-old male Balb/c nude mice through subcutaneous injection. Treatment doses of oregonin were administered three times weekly, for 30days from the 11th day after transplantation of the melanoma cells, in each group. The study consisted of a control group, a dacarbazine group, an oregonin group and a dacarbazine + oregonin group. Measurements were taken before treatment and on the 5th, 7th, 10th and 15th days after treatment for each group. Based on survival rates after transplantation, the control group showed less than 50% survival after 20days, while the treatment groups showed at least 50% survival up to the 41st day.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14107)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.